Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × Sodium Chloride × Clear all

NCT00967512 2014-09-18

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute